About this trial
This is a pilot randomized controlled trial, wherein the intervention group will undergo NMES five days a week beginning three weeks postoperative and lasting for ten weeks. Both the control and intervention groups will start standard physical therapy six weeks postoperative. Primary outcome measure will be the isometric strength of the gastrocnemius muscle. The secondary outcomes will comprise subjective clinical evaluations (using the Lower Extremity Functional Scale \[LEFS\]), functional assessments such as the sit-to-stand test, 2-minute walk test, stair climb test and objective clinical evaluation using contralateral comparison of calf circumference.
Eligibility criteria
Qualifiers
Capable and willing to provide informed consent
Undergoing a procedure that involves repairing an ankle fracture.
Disqualifiers
Rheumatoid arthritis
Connective tissue disorders
Chronic corticosteroid use
Implanted electrical devices
Trial design
Treatments tested in this trial
- VPOD Wireless Tens Unit
- Physical Therapy
- Biodex